A Disease That Touches Nearly Everyone, Eventually
Cancer is the second leading cause of death in the world, after cardiovascular disease. Every year, an estimated 20.6 million people are newly diagnosed, and close to 10 million die from it, more than 26,000 deaths every single day. By 2050, global cancer cases are projected to nearly double, driven largely by aging populations and rising rates of preventable risk factors. Very few families make it through a generation without cancer touching someone they know, whether it is a parent, a friend, a coworker, or a distant relative.
What makes cancer different from many other diseases on this list is that it is, to a significant degree, a disease of timing. Caught early, many cancers are treatable, sometimes curable. Caught late, the same disease can become a very different conversation. That single variable, how early a cancer is caught and how quickly proper treatment begins, is often the difference between recovery and loss.
The Numbers Behind the Silence
The global cancer burden is not just large. It is deeply unequal. Lung cancer remains the leading cause of cancer death worldwide, followed closely by breast, colorectal, and prostate cancers. But the outcome for any of these diagnoses depends enormously on where in the world a person happens to live. Women in Western Africa are twice as likely to die from breast cancer as women in Australia or New Zealand, despite having only about half the rate of diagnosis, a gap explained almost entirely by unequal access to screening and treatment, not by how aggressive the disease itself is. Across Africa more broadly, cancer incidence is often reported as lower than in wealthy nations, but mortality is significantly higher, because so many cases are diagnosed too late and treatment infrastructure is too thin to catch what could otherwise have been treatable.
There is a genuinely hopeful side to these numbers, too. Nearly 40 percent of all cancers are linked to preventable risk factors, and a substantial share of cancer deaths are considered avoidable altogether through early detection and timely treatment. In other words, a large part of the global cancer burden is not a story about an unbeatable disease. It is a story about a treatable disease that too often doesn't reach people in time.
Why Early Access Changes Everything
The long-term solution to cancer is not one cure for one disease; cancer is dozens of different diseases that behave differently, respond differently, and require different treatment. What connects almost every good outcome, across every type of cancer, is the same thing: early detection, and fast access to proper treatment once a diagnosis is made. Countries with strong screening programs and accessible treatment consistently show far lower mortality-to-incidence ratios than countries without them, even when the actual rate of diagnosis is similar or lower. Access, not diagnosis alone, is what decides survival in cancer more than in almost any other disease.
Where Research Is Headed
The progress in cancer treatment over the past two decades has been genuinely remarkable. Immunotherapy, which trains a patient's own immune system to fight cancer cells, has transformed outcomes for cancers that were once nearly always fatal; it's the same category of treatment that helped former U.S. President Jimmy Carter become cancer-free after a melanoma diagnosis that would have been considered untreatable a generation earlier. Targeted therapies now allow doctors to treat many cancers based on their specific genetic markers rather than a one-size-fits-all approach, improving both effectiveness and survival. On the prevention side, HPV vaccination is on track to make cervical cancer, once a leading cause of cancer death in women, largely preventable wherever the vaccine and follow-up screening are available. Global tobacco use has also declined significantly over the past fifteen years, directly reducing lung cancer rates in the countries where that decline has taken hold.
The tools to beat many cancers already exist. The determining factor, again and again, is whether a patient can reach them in time.
Why This Cause Is Personal to Me
I do not have cancer in my immediate family, but I have watched it move through my extended family and my circle of close friends more times than I can count. And what has stayed with me most is not the fear of the diagnosis itself. It is what happened after. In nearly every case, the people I know who received proper treatment, caught early and followed through, are still here today. Only one was not so fortunate.
That contrast is what drives me. I have seen, directly, what it looks like when someone gets access to the right treatment in time, and I have seen the one time it didn't happen that way. The difference wasn't the disease. It was access. That is why this fund exists, because I have watched, over and over, that cancer does not have to be a losing battle when the right care reaches someone in time, and I want more people to get that chance than the ones who don't.
Note before publishing: figures came from the WHO/IARC Global Status Report on Cancer 2026 and the American Cancer Society's 2026 global statistics release, both solid to cite publicly. The personal section here is different in tone from your other three since it's mostly a hopeful one, worth deciding if you want to keep that contrast or align it more closely with the others.
Fighting Cancer, One Patient at a Time
510-386-2575
© 2026 The Roy Foundation (theroyfoundations.org). All rights reserved